Qubit Pharma and CQT Initiate Drug Discovery Collaboration Using Quantum Algorithms
Qubit Pharmaceuticals and the Centre for Quantum Technologies have begun a two-year collaboration to enhance drug discovery through quantum algorithms. This partnership aims to overcome molecular simulation challenges, potentially leading to significant advancements in predicting molecular properties and simulating complex chemical systems.
Theia Market Signal Identification - AI Assisted
Qubit Pharmaceuticals has partnered with the Centre for Quantum Technologies in Singapore for a two-year research initiative focused on quantum chemistry algorithms. The collaboration aims to resolve computational bottlenecks in drug discovery, enhancing the accuracy of molecular property predictions and the efficiency of complex chemical simulations.
Initial work includes testing variational quantum eigensolvers and quantum Markov chain Monte Carlo algorithms on quantum simulators and hardware. Supported by Singapore's National Quantum Computing Hub, the project utilizes Quantinuum's systems for practical experimentation. If successful, this initiative could transition quantum algorithms from theoretical models to practical applications in drug discovery, influencing early decision-making in candidate molecule selection.
Comments